Chiara Lagorio: the Strategic Role of Lifestyle in the Management of Dyslipidemia
Chiara Lagorio, Research Dietitian at Candiolo Cancer Institute IRCCS, posted on LinkedIn:
“2025 European Society of Cardiology /European Atherosclerosis Society guidelines: the strategic role of lifestyle in the management of dyslipidemia.
The 2025 Focused Update of these LG ESC/EAS strongly confirms that prevenzione cardiovascolare can no longer be seen as a “lifestyle or drug therapy”, but as a real integrazione between risk assessment, nutritional intervention and pharmacological treatment when appropriate.
⸻
1. Risk assessment: the starting point
- New SCORE2 and SCORE2-OP algorithms: estimate the risk of fatal and non-fatal CV events up to 89 years.
- Introduction of risk modifiers (coronary calcium, vascular imaging) in borderline cases.
- The focus shifts from the single lipid value to the global cardiovascular risk profile: essential for deciding how much to focus on lifestyle and when to combine drug therapy.
⸻
2. Lifestyle: not an alternative, but the basis of treatment
- Diet, physical activity, weight control and fumo are at the forefront of all patients, at any risk level.
- Recommended model: DietaMediterranea → high in fiber and unsaturated fats, low in saturated fats and free sugars.
- Supplements not recommended in the absence of clinical evidence on cardiovascular events.
- As dietisti, our role is to ensure adherence, personalization and continuity over time.
⸻
3. Drug therapy: when lifestyle is not enough
- In high- and very high-risk patients, an early and strong strike approach is indicated.
- LDL -cholesterol confirmed as a causal factor of atherosclerosis: if the target is not reached, it is supplemented with statins ± ezetimibe ± PCSK9 or bempedoic acid inhibitors.
- Our contribution is critical to optimizing efficacy, reducing adverse metabolic effects, and improving aderenza.
⸻
4. Practical implications for us nutrition professionals
- Evaluate the patient in terms of overall cardiovascular risk, not just cholesterol values.
- Propose lifestyle as a terapia and not as simple advice.
- Collaborate with the doctor when drug therapy is indicated, with a view to therapeutic sinergia.
- Educare the patient to see prevention as a percorsointegrato, personalized and continuous.
⸻
In summary: effective cardiovascular prevenzione arises from the integration of lifestyle and risk-driven drug treatment. As nutrition professionals, we are an active part of the team in dislipidemie management and aterosclerosi prevention.
Source: Mach F, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal. 2025; doi:10.1093/eurheartj/ehaf190.”
Title: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Authors: François Mach, Konstantinos C Koskinas, Jeanine E Roeters van Lennep, Lale Tokgözoğlu, Lina Badimon, Colin Baigent, Marianne Benn, Christoph J Binder, Alberico L Catapano, Guy G De Backer, Victoria Delgado, Natalia Fabin, Brian A Ference, Ian M Graham, Ulf Landmesser, Ulrich Laufs, Borislava Mihaylova, Børge Grønne Nordestgaard, Dimitrios J Richter, Marc S Sabatine, ESC/EAS Scientific Document Group
Read full article here.
Stay informed with Hemostasis Today.
-
Feb 17, 2026, 09:04Mahesan Subramaniam: A Heart Attack Is a Long Story That Ends Fast
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood